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Nandita Khera, Eric J. Chow, Wendy M. Leisenring, Karen L. Syrjala, K. Scott Baker,
Mary E. D. Flowers, Paul J. Martin, Stephanie J. LeePreventive care guidelines are available for hematopoietic cell transplantation (HCT) survivors. We assessed
adherence to these guidelines and examined factors associated with lower adherence. A questionnaire was
mailed to adult HCT survivors to collect information regarding survivor health, adherence to recommended
guidelines, and financial concerns. Multivariate models identified patient and transplant characteristics asso-
ciated with lower adherence. Of the 3066 survivors at.2 years after HCT, 1549 (51%) responded. The me-
dian age of the respondents was 54.5 years, and the median adherence to recommended preventive care
based on age- and sex-specific recommendations was 75%. Lower adherencewas associated with autologous
HCT, concerns about medical costs, non-white race, male sex, lower physical functioning, absence of chronic
graft-versus-host disease, longer time since HCT, and poor knowledge of recommended tests. Although 98%
of the respondents hadmedical insurance, 26% expressed concerns about medical costs and reported efforts
to limit medical costs. A concern about medical costs was associated with female sex, age\65 years, absence
of chronic graft-versus-host disease, and low physical and mental functional status. Future efforts to improve
adherence should address concerns about medical costs and lack of knowledge, two major modifiable pre-
dictors of lower adherence to preventive care practices in HCT survivors.
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Hematopoietic cell transplantation (HCT) is used
to treat many malignant and nonmalignant conditions.
Improved supportive care strategies and transplanta-
tion techniques have led to an increasing population
of HCT survivors, drawing greater attention to their
unique problems and challenges. Observational stud-
ies have shown that HCT survivors are at greater
risk for chronic diseases and secondary cancers com-
pared with the general population [1-12].
One approach to improving the health and health-
related quality of life of HCT survivors is to enhance
the early detection and management of complications
through better preventive care. Specific recommenda-Clinical Research Division, Fred Hutchinson Cancer
rch Center, Seattle, Washington.
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HCT survivors have been developed based on litera-
ture reviews and consensus [13]. In addition, the US
Preventive Services Task Force recommendations for
preventive care for the general population [14] are
applicable to HCT survivors as well.
Several previous cross-sectional studies have charac-
terized health behaviors or health care utilization pat-
terns and adherence to survivorship recommendations
in HCT survivors [15-17]. The goals of the present
cross-sectional studywere to assess adherence to recom-
mended preventive care guidelines and to examine pre-
viously unstudied factors that might be associated with
adherence. We hypothesized that adherence would be
high inHCTsurvivors, but that certainpotentiallymod-
ifiable characteristics would predict lower adherence
with recommended screening tests.PATIENTS AND METHODS
Patients
This study was approved by the Institutional
Review Board at the Fred Hutchinson Cancer Re-
search Center (FHCRC). Survivors from the FHCRC995
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ered eligible for the study: age .18 years at the time
of the survey, previous transplantation at FHCRC,
current mailing address available, and survived for at
least 2 years after HCT irrespective of current disease
status.We could not locate approximately 5% of those
who had survived for $2 years after transplantation.
Eligible survivors were sent a self-administered survey
that asked about current health status and included
specific questions pertaining to preventive care and
financial concerns.Questionnaire
A 45-item module was developed to collect infor-
mation regarding adherence to preventive care guide-
lines and financial concerns. The survey was designed
based on literature review and pilot tested on a small
group of volunteer patients similar to the target popu-
lation before distribution. Feedback was collected
from the pilot group regarding the clarity of the ques-
tions and time taken to complete the module.
Respondents reported whether they had undergone
preventive health testing, such as general medical, den-
tal, eye, and gynecologic examinations. Specific items
assessed included blood pressure; stool occult blood;
sigmoidoscopy or colonoscopy; clinical breast examina-
tion, Pap smear, andmammography inwomen; and dig-
ital rectal examination for prostate cancer screening in
men. Information about blood tests, including thyroid
function, lipids, and prostate-specific antigen (in men),
also was collected. For each preventive measure, the
interval since the last test (\1 year, 1-2 years, 3-4 years,
or .5 years) was elicited. Additional questions asked
about the respondent’s level of interest in receiving
health maintenance reminders, self-perceived knowl-
edge about recommended testing for transplantation
survivors, andwillingness toparticipate in ahealthmain-
tenance study for transplantation survivors. The ques-
tionnaire did not ask for information about annual
household income, educational status, or type of health
care provider seen.
The financial section of the questionnaire inquired
about the availability of medical insurance coverage,
any worries about a lifetime cap, and bankruptcy due
to medical expenses. This section also asked whether
concerns regarding the cost of medical care led to 1
of 5 avoidance behaviors: cutting back on prescribed
medications; not purchasing a prescriptionmedication;
avoiding making appointments to see the doctor; not
using a medically related service, such as physical ther-
apy; and not having a medical test performed.
The supplementary module was added to a battery
of 236 questions mailed to survivors annually along
with general follow-up recommendations. Standard
questions asked about the numbers of hospitalizations
and outpatient visits, presence of chronic GVHD orother specific complications, and current medications.
Physical and mental functioning were assessed by self-
reported performance status and activity level, as mea-
sured by the Medical Outcomes Study Short Form 12
(SF-12) [18]. Age, sex, race and ethnicity, and informa-
tion about the HCT were available from the clinical
research database. The survey was mailed once to
each survivor along with a stamped, self-addressed
return envelope. No reminders were sent to nonre-
spondents, in accordance with the Long Term
Follow-up program’s policy for these questionnaires.
Data were collected between July 2008 and July 2009.Statistical Analysis
Current employment status was categorized hier-
archically in the following order, because a respondent
might be engaged in several activities: full-time work
outside the home, full-time school, part-time work
outside the home, part-time school, work at home, re-
tired, none of these. Concern about medical costs was
considered present if the respondent noted any of the 5
avoidance behaviors aimed at limiting costs. Lack of
knowledge about recommended tests was determined
based on the answer to the question: ‘‘Do you know
what tests are recommended for transplantation survi-
vors?’’ Groups were compared using the Wilcoxon
rank sum test or c2 test as appropriate.
Recommended screening tests were determined
from a literature review based on the respondent’s
current age and sex [13,14,19]. Although we used the
guidelines from 2006 to 2009 as our source, not many
of them are new and should be familiar to the health
care providers in the community. We used the
recommendations for adults, not for children [4], be-
cause only 8.7%of the respondents (n5 135) were chil-
dren at the time of HCT. A respondent was considered
adherent with screening recommendations if he or she
reported undergoing the screening test within an appro-
priate time interval plus a 1-year margin; for example,
because annual mammography is recommended for all
women age .40 years [13], a respondent age $40 was
considered compliant with the recommendation if she
reported having a mammogram within the past 2 years.
Multivariate logistic regression models were con-
structed for binary outcomes of ‘‘concerns about med-
ical costs’’ and ‘‘lack of knowledge about recommended
tests for survivors’’ considering sex, race, age, graft
source (bone marrow vs blood), conditioning regimen
(myeloablative vs nonmyeloablative), type of transplant
(autologous vs allogeneic), presence of chronic GVHD,
interval sinceHCT, andphysical andmental functioning
(high vs low) as candidate covariates. Proportional odds
regression models were constructed for the adherence
variable to evaluate associations between the ordinal
variables of.50% compliance and.75% compliance
using the foregoing covariates, as well as concerns
Biol Blood Marrow Transplant 17:995-1003, 2011 997Adherence to Preventive Care in HCT Survivorsaboutmedical costs and lackof knowledge.One factor—
current age—did not satisfy the proportional odds
assumption; for this covariate, the model was relaxed
to allow different odds ratios for each cutpoint [20].
Factors were included in final multivariate models if
their associated P value was\.10 or if their exclusion
markedly changed parameter values for other factors
in the model (.10% change). All reported P values
are two-sided.RESULTS
Of the 3066 survivors who were sent the question-
naire, 51% responded, a typical response rate for the
annual survey. Table 1 compares demographic and
disease-related characteristics of the respondents and
thenonrespondents.The respondentshad amedian cur-
rent age of 54.5 years, a median interval since HCT of
11.0 years, and a median interval since the most recent
evaluation at the transplantation center of 8.0 years.
The participants were 51% male and 95% white. The
nonrespondents were more likely to be younger, male,Table 1. Characteristics of Respondents and Nonrespondents
Respo
Number, % 1549 (5
Current age, years, median (range) 54.5 (1
Age at transplantation, years, median (range) 42.2 (0
White, n (%) 1379 (9
Missing or unknown 95
Hispanic or Latino, n (%) 35 (2
Missing or unknown 47
Male, n (%) 796 (5
Transplant type, n (%)
Autologous 415 (2
Related 748 (4
Unrelated 386 (2
Diagnosis, n (%)
Chronic leukemia 429 (2
Acute leukemia 352 (2
Lymphoma 282 (1
Multiple myeloma 121 (8
Myelodysplastic syndrome 170 (1
Aplastic anemia 92 (6
Solid tumor 53 (4
Other heme 19 (1
Other 14 (1
Missing 17
Posttransplantation relapse, n (%) 181 (1
Disease risk, n (%)
Low 599 (4
Intermediate 604 (4
High 308 (2
Missing 38
Graft source, n (%)
Peripheral blood 682 (4
Bone marrow 866 (5
Umbilical cord blood 1 (<
Myeloablative conditioning, n (%) 1424 (9
Missing 1
Time since transplantation, years, median (range) 11.0 (2
Time since last seen at FHCRC, years, median (range) 8.0 (0
Chronic GVHD, among allogeneic patients, n (%) 748 (6
*Two-sided P values from Wilcoxon rank sum tests for continuous variables aHispanic/Latino, and non-white; to have received
bone marrow, myeloablative conditioning, and alloge-
neic HCT; to have a lower disease risk; and to have lon-
ger intervals since HCT and since the most recent
evaluation at the transplantation center. There were no
significant differences in relapse status and presence of
chronic GVHD between the two groups.
As shown in Table 2, 85% of the respondents per-
ceived their general health as good to excellent, 44%
worked full time outside the home or went to school
full time, 56% were able to do their usual activities
without any limitation, and 76% reported seeing their
doctor within the past 3months (Table 2). Themedian
physical and mental component scores as derived from
the SF-12 were 51.0 (interquartile range, 38.9-55.8)
and 55.9 (interquartile range, 49.9-58.7), respectively.Adherence to Preventive Care Guidelines
After appropriate age- and sex-specific adjust-
ments, the overall median adherence to recommended
preventive care guidelines was 75%. No specific
screening tests accounted for lower adherence ratesndents Nonrespondents P Value*
1) 1517 (49)
8.2-81.8) 47.4 (18.0-82.3) <.001
.9-73.8) 32.6 (1.2-71.2) <.001
5) 1275 (93) .01
139
) 87 (6) <.001
54
1) 876 (58) <.001
.001
7) 343 (23)
8) 837 (55)
5) 337 (22)
.001
8) 422 (28)
3) 453 (30)
8) 239 (16)
) 66 (4)
1) 109 (7)
) 118 (8)
) 54 (4)
) 33 (2)
) 8 (1)
15
2) 157 (10) .24
.005
0) 664 (45)
0) 514 (35)
0) 284 (19)
55
<.001
4) 536 (35)
6) 975 (64)
1) 6 (<1)
2) 1449 (96) <.001
7
.6-38.0) 13.1 (2.5-36.7) <.001
-37.0) 10.4 (0-35.3) <.001
6) 731 (62) .064
nd from c2 tests for categorical variables.
Table 2. Current Health Status
Characteristic n (%)
General health
Excellent 288 (19)
Very good 547 (36)
Good 477 (31)
Fair 188 (12)
Poor 29 (2)
Missing 20
Karnofsky performance status (self-reported)
100% 753 (49)
90% 436 (28)
80% 152 (10)
#70% 192 (13)
Missing 16
Work status
Full-time work outside the home 627 (41)
Full-time school 43 (3)
Part-time work outside the home 192 (12)
Part-time school 14 (1)
Work at home 125 (8)
Retired 421 (27)
None of these 117 (8)
Missing 10
Ability to do usual job, housework, or school work
Yes, doing this without limitation 851 (56)
Yes, but limited a little 415 (27)
Yes, but limited a lot 167 (11)
No, unable to do these things 84 (6)
Missing 32
Number of physician appointments during the last 3 months
None 367 (24)
One 522 (34)
Two 256 (17)
Three or more 381 (25)
Current chronic GVHD
No 815 (72)
Yes 245 (22)
Don’t know 66 (6)
GVHD medications currently taken (allogeneic only)
None 932 (83)
At least one of the following: 202 (17)
Corticosteroids 106 (10)
Cyclosporine or tacrolimus 84 (7)
Mycophenolate mofetil 31 (3)
Sirolimus 24 (2)
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relies on physical examination ranged from 61% for
a skin examination to 92% for breast examination. Ad-
herence to laboratory testing ranged from 50% for
thyroid function tests to 91% for cholesterol testing.
Rates of adherence to specialized testing were high, in-
cluding 82% for colonoscopy or sigmoidoscopy, 84%
for Pap smear, and 90% for mammography (Table 3).Patient Participation in Preventive Health Care
Most respondents (87%) were interested in some
form of assistance with health maintenance from the
transplantation center, primarily in the form of mailed
information. A minority (27%) reported they felt
knowledgeable about recommended tests for trans-
plantation survivors, whereas 46% of respondents in-
dicated that they ‘‘did not know but would like to,’’
and 26% indicated that they ‘‘did not know and relied
on the doctor to know’’ (Table 4).Influence of Financial Factors on Health
Behaviors
Although 98% of the respondents had medical
insurance coverage, 26% reported attempts to limit
medical costs by engaging in one or more potentially
deleterious health behaviors. Twenty-six percent wor-
ried that medical expenses would reach their lifetime
limit, 1% reported that they had already reached their
limit, and 3% reported filing for bankruptcy due to
medical expenses (Table 5).
Regression Models
An ordinal regression analysis demonstrated that
lower adherence rates were associated with autologous
HCT, concerns about medical costs, an interval of
.15 years since HCT, non-white race, male sex, lower
physical functioning, absence of chronic GVHD, youn-
ger current age (\40 years), and self-reported lack of
knowledge about the recommended tests (Table 6). An
association with Hispanic ethnicity could not be tested
becauseof the small number ofHispanic/Latino respon-
dents (n 5 35; 2.3%). Multivariate logistic regression
modeling indicated that concerns about medical costs
were associated with lower physical and mental func-
tioning, age\65 years, and female sex and marginally
associated with absence of chronic GVHD. Lack of
knowledge about recommended tests for survivors was
more common in males, those who underwent auto-
logous HCT, those who did not develop chronic
GVHD, non-whites, those age .65 years, and those
with a.15-year interval after HCT (Table 7).DISCUSSION
HCT survivors are at higher risk of developing ad-
verse medical conditions and new malignancies com-
pared with the general population. The present study
found high rates of self-reported adherence to screening
practices among the respondents. These rates are higher
than those reported for the general population by the
National Center for Health Statistics in 2008; for in-
stance, 90% of our female respondents aged .40 years
had undergone a mammogram in the past 2 years, com-
paredwith68%of thegeneralpopulation [21].Likewise,
82% of our respondents aged.50 had undergone colo-
noscopy/sigmoidoscopy, compared with 61.8% of the
general population [22].
In general, the high preventive screening rates
reported by our HCT survivors are in agreement
with findings in some, but not all, studies of cancer sur-
vivors. Mayer et al. [23] reported screening adherence
rates in cancer survivors exceeding American Cancer
Society recommendations, national prevalence data,
and Healthy People 2010 goals for individual tests.
Trask et al. [24] reported similar findings and also
noted varying adherence rates for different types of
Table 3. Adherence to Recommended Preventive Care
Time Since Last Testing, n (%)
Asymptomatic Target
Population and Recommended
Frequency of Testing
Number
Eligible <1 Year 1-2 Years 3+ Years Never
Do Not
Recall Missing
Recommended preventive care used to determine adherence rate
Tooth cleaning and dental
examination
All, annually [13] 1549 1229 (81) 164 (11) 114 (7) 7 (1) 11 (1) 24
Thyroid blood test All, annually [13] 1549 578 (39) 160 (11) 122 (8) 187 (12) 452 (30) 50
Blood pressure test All at every clinic visit, at least
every 2 years [13,14]
1549 1401 (92) 61 (4) 15 (1) 17 (1) 29 (2) 26
Cholesterol test Women aged >45 years and men
aged >35 years, every
5 years [13,14]
1287 918 (73) 170 (13) 64 (5) 25 (2) 85 (7) 25
Stool occult blood test All aged >50 years, annually
[13,14,19]
997 235 (25) 162 (17) 219 (23) 119 (13) 212 (22) 50
Colonoscopy/sigmoidoscopy All aged >50 years, every 5 years
for sigmoidoscopy and every
10 years for colonoscopy
[13,14,19]
997 201 (21) 202 (21) 383 (40) 122 (13) 58 (6) 31
Skin examination by professional All, annually [19] 1549 705 (47) 205 (14) 237 (16) 188 (12) 174 (12) 40
Skin examination by patient
or family
All, annually [19] 1549 883 (59) 83 (6) 72 (5) 287 (19) 168 (11) 56
Gynecologic examination Women aged >21 years, annually
[13,19] or at least every
3 years [14]
753 488 (66) 150 (20) 73 (10) 7 (1) 22 (3) 13
Pap smear Women aged >21 years, annually
[13,19] or at least every
3 years [14]
753 472 (64) 151 (20) 88 (12) 12 (2) 18 (2) 12
Breast examination Women aged 20-40 years every
3 years; women aged >40 years,
annually [19]
753 558 (76) 120 (16) 41 (6) 8 (1) 12 (2) 14
Mammogram Women aged >40 years, annually
[14,19]
641 457 (73) 107 (17) 39 (6) 13 (2) 7 (1) 18
Additional preventive care testing not considered in adherence rate
Eye examination All, 1 year posttransplantation [13] 1549 897 (59) 401 (26) 198 (13) 15 (1) 14 (1) 24
Bone density test, women All women and those who received
steroids or calcineurin inhibitors
1 year posttransplantation [13]
and women aged > 60 years [14]
753 257 (35) 211 (29) 159 (22) 54 (7) 48 (7) 24
Bone density test, men All men and those who received
steroids or calcineurin inhibitors
1 year posttransplantation [13]
and men aged >60 years [14]
796 118 (15) 115 (15) 198 (26) 195 (25) 140 (18) 30
Prostate-specific antigen No recommendation [13,14,19] 796 309 (39) 112 (14) 60 (8) 137 (17) 169 (21) 9
Digital rectal examination No recommendation [13,14,19] 796 242 (31) 144 (19) 155 (20) 142 (18) 89 (12) 24
Shaded boxes indicate compliance with recommended guidelines.
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of preventive services by elderly breast cancer survivors
compared with controls.Within anHCT survivor pop-
ulation, Shankar et al. [17] reported a greater frequency
of physical examinations and general medical contact
compared with sibling controls. These high screening
rates may indicate increased survivor awareness and at-
tention to preventive care due to the so-called ‘‘teach-
able moment’’ effect [26], in which survivors, having
survived one life-threatening disease, are more moti-
vated to try to prevent additional illness.
In contrast, other studies have reported lower rates
of preventive care in cancer survivors compared with
the general population. For instance, the Childhood
Cancer Survivor study found suboptimal adherence
to recommended guidelines among survivors of child-
hood cancers [27,28], and a study by Earle and Neville
[29] found lower rates of adherence to recommendedscreening practices in colorectal carcinoma survivors
compared with controls. Bishop et al. [15] reported
that compared with healthy controls, their HCT survi-
vor group had similar rates of breast and colorectal
cancer screening but a lower rate of Pap smears. Prasad
et al. [16] compared non-Hispanic and Hispanic HCT
survivors and reported lack of insurance, poor English
proficiency, and lack of concern for future health as
factors associated with lower health care utilization
in the Hispanic cohort.
Lower adherence to preventive care recommenda-
tions could be explained by problems related to the pa-
tient, the physician, or the health care delivery system.
For example, a person who has survived one bout of
cancer might avoid cancer screening because of in-
creased anxiety about discovering a second malig-
nancy. Poor mental and physical functioning due to
cancer or treatment-related complications might
Table 4. Patient Participation in Preventive Health Care
Characteristic n (%)
Interest in health maintenance programs
None 199 (13)
At least one of the following: 1313 (87)
Annual 1-day clinic visit to prevent health problems 364 (24)
Mailed information annually about recommended tests 965 (64)
Yearly telephone call to discuss recommended tests 408 (27)
Mailed reminders of due dates for recommended tests 683 (45)
Missing 37
Keeps records of medical tests and results 930 (61)
Missing 30
Knowledge of recommended tests for transplantation
survivors
Yes 418 (27)
No, but would like to know 702 (46)
No, rely on doctor to know 401(26)
Missing 28
Willingness to participate in a study of the best ways to help
survivors maintain health
Yes, definitely 652 (43)
Yes, probably 591 (39)
No 268 (18)
Missing 38
Breast self-examination; optional for women age >2019
(n 5 805)
Regularly (once a month) 232 (31)
Occasionally 360 (49)
Rarely or never 146 (20)
Missing 15
Testicular self-examination; annually for men;19
not recommended by USPSTF14 (n 5 869)
Regularly (once a month) 140 (19)
Occasionally 259 (35)
Rarely or never 343 (46)
Missing 54
Table 5. Insurance Status and Concerns about Medical Costs
Characteristic n (%)
Medical insurance*
Medical insurance 1153 (74)
Medicare/Medicaid 457 (30)
VA 75 (5)
Other 152 (10)
None 24 (2)
Denied coverage because of cancer or cancer treatment 154 (11)
Missing 163
Availability of employee group medical coverage is
an important reason why working at current job
471 (37)
Missing 274
Cost of medical care has caused:
No change in use of medical care 1121 (74)
At least one of the following: 392 (26)
Cutting back on prescribed medications taken 158 (10)
Not purchasing a prescription medication 166 (11)
Avoiding making appointments to see physician 226 (15)
Not using a medically related service, such as
physical therapy
193 (13)
Not having a medical test performed 187 (12)
Missing 37-44
Worried that expenses will reach the limit and the
insurance company will stop paying
368 (25)
Missing 57
Insurance company has already stopped paying because
cap exceeded
19 (1)
Missing 69
Filed bankruptcy because of medical expenses 40 (3)
Missing 46
*May have multiple insurance types; sum >100%.
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style and/or obtain aggressive preventive care. A pre-
scribing physician might be more familiar with US
Preventive Services Task Force (USPTF) guidelines
and less aware of specific screening guidelines for
HCT patients. A pediatric study found that many
pediatric oncologists who care for long-term cancer
survivors are not familiar with available guidelines
for surveillance of late effects [30]. This could account
for the association between younger age and lower ad-
herence, given that most USPTF guidelines apply to
older adults and thus are most applicable to the older
age group. An ongoing National Cancer Institute–
American Cancer Society collaborative study is com-
paring the perceived roles, knowledge, and practices
of primary care physicians and oncologists with regard
to follow-up survivorship care, with results expected
by the end of 2010.
Lack of a regular source of health care and lack of
access to health insurance also have been cited as risk
factors for suboptimal utilization of health care services
in cancer survivors and the general population alike
[31,32]. Although numerous studies have examined
the clinical consequences of being uninsured [33-36],
few studies have investigated the health consequences
of financial barriers to medical care for the so-called
‘‘underinsured’’ population, especially in the HCTsetting. A recent study of health care disparities in can-
cer survivors reported a prevalence of forgoing one or
more medical services due to cost of 17.6% [37]. In
a survey of the general population, 3%-4% of insured
men and 5%-8% of insured women reported not hav-
ing received needed prescription medications or medi-
cal care because of cost concerns [38]. Our study found
a much higher rate of concerns about medical costs
than that seen in both the general population and can-
cer survivors; 26% of our respondents reported poten-
tially risky avoidance behaviors related to concerns
about medical costs, even though nearly all of the
respondents (98%) had insurance coverage.
In addition to cost concerns, lower adherence
was predicted by male sex and non-white race, factors
associated with adverse health behaviors and decreased
health utilization in previous studies [15-17,39].
Interestingly, absence of chronic GVHD also
emerged as a predictor for lack of knowledge and
thus lower adherence. This could be explained by the
fact that patients with chronic GVHD have more
frequent follow-up with the transplantation center
and receive reminders of preventive care recommenda-
tions at each visit. Similarly, the lack of follow-up with
the transplantation center after autologous HCT due
to less need for continued specialized posttransplanta-
tion therapy could possibly explain our finding of
lower adherence and greater likelihood of lack of
knowledge in autologous HCT survivors. Another
Table 6. Multivariate Proportional Odds Regression Models for Ordinal Categories of Adherence to Recommended Preventive
Care, with Cutpoints at <50% and <75%
Common OR 95% CI P Value
Male 2.81 2.27-3.49 <.001
Autologous transplantation 1.69 1.30-2.19 .001
Concerns about medical costs 1.48 1.15-1.89 .002
Time since transplantation
<5 years 1.0 - -
5-9.9 years 0.88 0.63-1.22 .44
10-14.9 years 1.08 0.71-1.64 .58
$15 years 1.42 1.03-1.94 .02
Non-white 1.90 1.21-3.00 .006
Physical function <-1 SD 1.43 1.11-1.85 .006
Absence of chronic GVHD 1.80 1.29-2.50 <.001
Lack of knowledge 2.00 1.57-2.56 <.001
<75% Compliance <50% Compliance
OR 95% CI P Value OR 95% CI P Value
Current age
$65 years 1.0 - - 1.0 - -
55-64.9 years 0.98 0.71-1.36 .92 1.08 0.72-1.63 .69
40-54.9 years 0.47 0.32-0.69 <.001 1.25 0.78-2.00 .36
<40 years 1.08 0.71-1.64 .71 2.14 1.32-3.47 .002
Biol Blood Marrow Transplant 17:995-1003, 2011 1001Adherence to Preventive Care in HCT Survivorspossible contributing factor could be physicians’ per-
ceptions of lower intensity of previous treatment and
susceptibility to complications in autologous HCT
survivors compared with allogeneic HCT survivors.
This result is in contrast to the findings of Bishop
et al. [15] that autologous HCT survivors were more
likely to report breast or cervical cancer screening,
with no significant difference in the rate of all sug-
gested cancer screening tests between allogeneic and
autologous HCT survivors. One possible explanation
for the discrepancy is that compared with our study,
the study of Bishop et al. included a higher percentageTable 7. Multivariate Logistic Regression for Concerns about Medi
Dependent Variable Covariate
Concern about medical cost
Physical functioning <-1
Mental functioning <-1 S
Age, years
$65
50-64.9
40-49.9
<40
Male
No chronic GVHD
Lack of knowledge about recommended tests
for survivors
Male
Absence of chronic GVH
Autologous transplantat
Time since transplantatio
<5 years
5-9.9 years
10-14.9 years
$15 years
Non-white
Age $65 years
*Category-specific P value from the Wald test is shown when different from t
†Global P value for covariate.of patients who underwent autologous HCT for breast
cancer, a situation in which breast and cervical cancer
screening might be emphasized. Our multivariate
analysis also identified longer time since transplanta-
tion as a risk factor for lower adherence, in agreement
with a report from the Childhood Cancer Survivor
Study [39]. This finding might be linked to a poor
understanding of the late effects of therapy if patients
and physicians believe that the risk declines over time.
Our study has some limitations. Approximately half
of the eligible survivors did not return the survey. The
nonrespondents were more likely to have characteristicscal Costs and Lack of Knowledge about Recommended Tests
OR 95% CI P Value* P Value†
SD 2.68 2.03-3.53 <.001
D 2.32 1.65-3.27 <.001
1.0 - - <.001
2.42 1.57-3.74 <.001
3.98 2.50-6.36 <.001
3.10 1.88-5.14 <.001
0.64 0.50-0.82 <.001
1.40 0.98-2.00 .06
1.44 1.13-1.83 .003
D 1.46 1.05-2.03 .03
ion 1.54 1.13-2.11 .007
n
1.0 - - <.001
0.92 0.64-1.32 .65
0.79 0.54-1.14 .20
1.62 1.12-2.34 .010
1.90 1.02-3.54 .042
1.41 1.01-1.97 .043
he overall variable level P value.
1002 Biol Blood Marrow Transplant 17:995-1003, 2011N. Khera et al.associated with lower adherence, suggesting that our
findings might be an overestimation of the population
adherence rates and thus represent the best-case sce-
nario. Despite this, our analyses are valid for the
50% of patients who responded to the survey (n 5
1549), reflecting a large number of survivors in
whom preventive care adherence is good but still could
be improved to hopefully minimize long-term compli-
cations. We also acknowledge that this was a single-
center study from the United States, and results might
differ depending on the follow-up practices and re-
sources for disseminating information about these
guidelines at other transplantation centers worldwide.
In addition, adherence rates were calculated on the
basis of self-report and were not validated by a review
of patient records from treating physicians. This could
have led to an overestimation of adherence rates,
given that self-reported data about health behaviors
might be affected by a social desirability bias [40-42].
It also raises the possibility of participant bias,
because participants who return health surveys are
usually more driven to maintain optimal health by
utilizing health services and adopting healthy lifestyle
behaviors. Another limitation of the present study
stems from nontransplantation physicians’ possible
lack of awareness of guidelines for long-term follow-
up of HCT survivors. Because we did not collect infor-
mation on the types of providers following the patients,
we cannot comment on whether this factor might be
associated with lower adherence. Another important
study limitation is that we did not ask the survivors
questions regarding lifestyle practices. For certain
cancers that are not amenable to easy screening proce-
dures, it might be more important to maintain
a healthy lifestyle than to adhere to recommended
medical testing alone. For instance, in the case of
skin cancer, for which prevention by avoiding unpro-
tected UV exposure may be of comparable benefit to
regular skin examinations, it would have been interest-
ing to examine whether low adherence to recommen-
ded screening was associated with nonadherence to
preventive behaviors, such as use of sunscreen. Finally,
in examining financial concerns, we did not specifically
assess whether the perceived cost burden was due to
high out-of-pocket costs, low lifetime caps, or lack of
catastrophic provisions.
Our findings suggest that future attempts to im-
prove survivors’ adherence to preventive practices
would benefit from attention focused on patients’ fi-
nancial concerns and lack of knowledge, given that
both are potentially modifiable factors and might
have emerged as even stronger predictors had we in-
cluded our nonrespondent group in the analysis. For
example, better communication with patients about
the reasons for screening recommendations and frank
discussion about financial implications along with
approaches to mitigate personal costs might improveadherence. Given the high rate of financial concerns
related to medical care in our study cohort, national
policies that ensure affordable health insurance cover-
age would help alleviate those stresses. The Affordable
Care Act is a step in the right direction, because it aims
to make wellness and preventive services affordable
and accessible by requiring health plans to cover these
services and by eliminating cost-sharing.
Our findings also highlight the need to redesign
health insurance benefits packages to include incen-
tives to adopt healthy lifestyle practices. Another
important intervention to improve patient and physi-
cian knowledge may be the provision of comprehen-
sive survivorship care plans [43] by transplantation
centers, similar to those that have been developed for
breast and colon cancer survivors by the American
Society of Clinical Oncology [44]. Although there is
a paucity of data on the effectiveness of these plans in
improving patient knowledge and adherence to pre-
ventive practices, providing a diagnostic and treatment
summary along with follow-up recommendations that
identify the physician who will implement them likely
will improve coordination of care [45]. A recent study
reported that a survivorship care discussion between
patients and physicians might have positive effects on
some aspects of follow-up care [46]. Finally, efforts
to provide community outreach education and support
programs to exploit the ‘‘teachable moment’’ [26]
provided by the transplantation process itself may en-
courage healthy behaviors. These strategies should be
tested in future studies to evaluate whether they will
result in improved adherence to preventive guidelines
and ultimately lead to improved health-related quality
of life and decreased morbidity and mortality.ACKNOWLEDGMENTS
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